Exponential spur of growth in Targeted Protein Market

Targeted protein degradation is an emergent modality that allows access to difficult-to-treat diseases. While traditional medicines such as small molecule inhibitors and monoclonal antibodies address fewer than 20% of the proteome, targeted degradation offers an exceptional means to tap into the rest of the vast, unexplored proteome.


Targeted protein degradation


Through this, a disease can be addressed by controlling the amount of a harmful protein rather than trying to modulate or inhibit its function. The control of protein levels is accomplished with a small molecule drug called a protein degrader.

Other Types Of Targeted Protein Degraders

Currently, there are several other types of targeted protein degraders and molecular glues, which have been / are being developed for the treatment of a variety of clinical conditions, including acute myeloid leukemia, Alzheimer's disease, breast cancer, myelofibrosis, multiple myeloma, Parkinson's disease, prostate cancer, psoriasis, rheumatoid arthritis, and supranuclear palsy.

Other types of targeted protein degraders


It is worth noting that the R&D efforts in this field are supported by DNA-encoded libraries and other in silico hit discovery and characterization tools. In the last 4-5 years, there has been a marked rise in the number of new entrants in this market. Additionally, several big pharma players are also actively involved in this field, appraising proprietary protein degrader-based therapeutic leads.

The market has also witnessed considerable partnership activity over the last few years, with several technology developers involved in high-value licensing deals. While, there are no approved protein degrader-based drugs / therapy products, the market is poised to witness healthy growth over the next decade.

Proteolysis targeting chimera (PROTAC), developed by Hashimoto Laboratory in 2008, was the primary targeted protein degrader. The continuous efforts of researchers involved in this domain have resulted in significant development towards understanding the physiochemical and biological properties of such bifunctional molecules.

What is the current trend in the domain?

As per a current market report by us, there are more than 85 small molecule protein degraders are currently being assessed for the treatment of various disease indications. In addition, there are 25+ technology platforms available for use in therapy development efforts.

small molecule protein degraders


In fact, the growing popularity of targeted protein degradation is evident in the USD 5 billion in capital investments made into companies engaged in this field of research, since 2014.

Our market report includes, tabulated profiles of leading industry players (shortlisted on the basis of the number of candidates in development pipeline). Each profile includes details on the innovator company (such as year of establishment, location of headquarters, number of employees, and key members of the executive team), recent developments, along with information on corresponding drug applicants.


Comments

Post a Comment

Popular posts from this blog

The Cell Therapy Manufacturing Market, Industry Analysis And Global Forecast, 2019-2030

Image
 For various reasons, the demand for cell therapies is expected to increase in the coming years. Therefore, both therapy developers and contracted service providers may need to strengthen their skills and expand available capacity. In this regard, automation is expected to be a key enabler in the cell therapy manufacturing and contract services industry. Growing at an annualized rate of more than 16.5%, the  cell therapy manufacturing market is projected to reach close to USD 11 billion by 2030, according to Roots Analysis. Cell therapy manufacturers are also gradually choosing to automate various operations in the supply chain; The main goal is to achieve favorable bench-to-clinic timelines and to reduce production-related losses. Currently, the installed global capacity for cell therapy manufacturing is estimated to be spread across 1.2+ million square feet of dedicated cleanroom area distributed across various scales of operation. It has been estimated that more th...
Read more

At-home Self Testing Kits Market | Market Size | Industry Analysis | 2035

Image
  In the health industry, digitization has evolved over time with numerous advances to ensure that everyone has equitable access to health products and medical specialists. Self-testing has the ability to improve health equity and accelerate progress toward universal health coverage, and it has the capacity to alter health care. Self-testing alternatives provide individuals and communities with simple, quick, and private means to diagnose and treat a rising range of diseases, including HIV, hepatitis C, COVID-19, and, most recently, syphilis. People can now direct their own illness screening and make decisions based on their results safely, effectively, securely, and conveniently thanks to the introduction of more accessible and affordable self-tests and the expanding self-care movement. At-home Self-testing Kit Manufacturers — Current Market Landscape Currently, more than 650  at-home self-testing kits  are available worldwide and are approved by regulatory authorities. ...
Read more

RNA Extraction and Purification Kits, Reagents, and Instruments Market | Industry Analysis, 2022-203

Image
  More than 740 RNA Extraction and Purification Kits are Commercially Available in the Market; Around 70% of These Kits Deploy Spin Column Technology for Extraction and Purification of RNA Amongst the total players involved in the development of RNA extraction and purification kits and reagents, majority of the players engaged in the development of RNA extraction and purification kits were established between 1981–2000. RNA extraction and purification kits and reagents During our research, we were able to identify more than 60 developers were involved in the development of RNA extraction and purification kits and reagents. The RNA extraction and purification kits market is currently dominated by the presence of small companies. This is followed by the presence of well-established players in this domain. Further, most of the manufacturers of RNA extraction kits are headquartered in North America. Within this region, the US has emerged as the most prominent region, having the highes...
Read more